Exane Derivatives’s Vipshop VIPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-70
Closed -$630 984
2022
Q1
$630 Buy
+70
New +$617 ﹤0.01% 842
2021
Q4
Sell
-70
Closed -$780 1035
2021
Q3
$780 Hold
70
﹤0.01% 892
2021
Q2
$1.37K Hold
70
﹤0.01% 846
2021
Q1
$2.09K Hold
70
﹤0.01% 676
2020
Q4
$1.97K Hold
70
﹤0.01% 628
2020
Q3
$1.09K Hold
70
﹤0.01% 612
2020
Q2
$1.39K Sell
70
-18,930
-100% -$325K ﹤0.01% 535
2020
Q1
$296K Buy
+19,000
New +$270K 0.08% 160
2019
Q3
Sell
-73,197
Closed -$631K 702
2019
Q2
$631K Sell
73,197
-238,684
-77% -$1.92M 0.11% 147
2019
Q1
$2.5M Buy
311,881
+55,591
+22% +$394K 0.49% 64
2018
Q4
$1.4M Buy
256,290
+39,200
+18% +$211K 0.25% 94
2018
Q3
$1.37M Buy
217,090
+80,274
+59% +$660K 0.26% 89
2018
Q2
$1.49M Buy
+136,816
New +$1.87M 0.25% 86

Other funds holding VIPS

Exane Derivatives's VIPS Position: Q2 2022 in Review

Exane Derivatives sold out of Vipshop (VIPS) in Q2 2022, closing a stake of 70 shares — an estimated $630 sold.

Exane Derivatives first reported a position in VIPS in Q2 2018 and held it in 13 quarters. The position peaked at $2.5M in Q1 2019. 253 funds tracked by Wall St. Rank hold VIPS as of Q2 2022.

  • Exane Derivatives reported no remaining Vipshop position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 70 Vipshop shares in Q2 2022, an estimated $630.
  • Exane Derivatives first reported a position in Vipshop in Q2 2018 and held it in 13 quarters.
  • Exane Derivatives's Vipshop position peaked at $2.5M in Q1 2019.
  • 253 funds tracked by Wall St. Rank held Vipshop as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.